Status:
COMPLETED
Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers
Lead Sponsor:
Tanta University
Conditions:
Amniotic Membrane Extract Eye Drops
Resistant Corneal Ulcers
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study aimed to assess the efficacy of amniotic membrane extract eye drops (AMEED) as a supplementary treatment for refractory corneal ulcers.
Detailed Description
Corneal ulceration is one of the leading causes of corneal blindness. Multiple causes of corneal ulceration vary in prevalence from country to country according to geographical and economic conditions...
Eligibility Criteria
Inclusion
- Age from 20 to 80 years.
- Both sexes.
- Patients who were suffering from corneal ulcers that showed no signs of improvement after one week of medical intervention.
Exclusion
- Severe corneal melting.
- Perforated corneal ulcer.
- Corneal ulcers with significant thinning with or without descemetocele.
- Patients who were unable to adhere to the treatment plan properly.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06909149
Start Date
May 1 2019
End Date
May 1 2022
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527